1. Home
  2. BANF vs AMLX Comparison

BANF vs AMLX Comparison

Compare BANF & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BancFirst Corporation

BANF

BancFirst Corporation

HOLD

Current Price

$106.83

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

BUY

Current Price

$27.09

Market Cap

3.8B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BANF
AMLX
Founded
1984
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.8B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
BANF
AMLX
Price
$106.83
$27.09
Analyst Decision
Hold
Strong Buy
Analyst Count
3
12
Target Price
★ $124.00
$42.36
AVG Volume (30 Days)
107.2K
★ 1.4M
Earning Date
10-20-2026
11-05-2026
Dividend Yield
★ 1.95%
N/A
EPS Growth
10.40
★ 65.46
EPS
★ 3.81
N/A
Revenue
N/A
★ $380,786,000.00
Revenue This Year
$8.64
N/A
Revenue Next Year
$7.04
N/A
P/E Ratio
$28.06
★ N/A
Revenue Growth
N/A
★ 1612.94
52 Week Low
$101.48
$10.83
52 Week High
$126.14
$41.14

Technical Indicators

Market Signals
Indicator
BANF
AMLX
Relative Strength Index (RSI) 43.29 36.48
Support Level $106.28 $12.97
Resistance Level $116.82 $34.35
Average True Range (ATR) 2.06 1.36
MACD 0.01 -0.61
Stochastic Oscillator 45.36 17.50

Price Performance

Historical Comparison
BANF
AMLX

About BANF BancFirst Corporation

BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Its Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Share on Social Networks: